Résultats de la recherche - 5 results
Point prevalence survey of antimicrobial use and healthcare-associated infections in Belgian acute care hospitals: results of the Global-PPS and ECDC-PPS 2017.
the ECDC or Global- PPS. Hospital/ward/patient-level data were collected between September-December 2017. All patients present in the wards at 8 a.m. on the day of the PPS were included. The data of the ...
Antimicrobial use in European long-term care facilities: results from the third point prevalence survey of healthcare-associated infections and antimicrobial use, 2016 to 2017
confidence interval: 4.8–5.1) of LTCF residents in the EU / EEA participating countries received at least one antimicrobial. The most commonly reported Anatomical Therapeutic Chemical (ATC) groups were ...
Point Prevalence Study of Healthcare-Associated Infections and Antimicrobial Use in Belgian Acute-Care Hospitals: Results of the ECDC PPS 2017
(ECDC). In the participating Belgian acute care hospital sites (N=52, September-December 2011), the prevalence of patients with at least one antimicrobial and at least one HAI was 28.9% (95% confidence ...
Surveillance of antimicrobial resistant bacteria in Belgian hospitals: Report 2016
former Belgian Scientific Institute of Public Health) closely monitors antimicrobial resistance in Belgian acute care hospitals. At present, hospitals can participate in three national, multicentric and ...
European Antimicrobial Resistance Surveillance Network (EARS-Net Belgium)- Report 2017 (Data up to and including 2016)
Resistance Surveillance Network (EARS-Net) monitors the evolution of acquired antimicrobial resistance at the European level. The Scientific Institute of Public Health (WIV- ISP) is the nominated focal contact ...